Key result
A laboratory-based frailty index (FI-Lab21) score greater than 0.5 was associated with a significantly increased risk of 1-year mortality (HR 6.507) compared to a score of 0-0.1 in elderly patients with hip fractures.
Why the study?
To develop a laboratory-based frailty index (FI-Lab) to predict 12-month mortality risk in elderly patients following a hip fracture.
Does a laboratory-based frailty index predict 1-year mortality in elderly patients following hip fracture surgery?
Cohort (n=235)
No
Does a laboratory-based frailty index predict 1-year mortality in elderly patients following hip fracture surgery?
Hazard Ratio: 6.507 (95% CI 2.751–17.89)
p-value: p=<0.0001
A 21-parameter laboratory-based frailty index (FI-Lab21) provides a practical and valid tool for predicting 1-year mortality in elderly patients undergoing hip fracture surgery.
FI-Lab21 may stratify 1-year mortality risk after hip fracture; leaves open prospective validation before clinical adoption.
This study aimed to develop a laboratory-based frailty index (FI-Lab) to predict 12-month mortality risk in elderly patients following a hip fracture (HF). A retrospective analysis of 235 consecutive patients over 70 years old, who underwent HF surgery, was conducted. The FI-Lab, based on 21 routine blood parameters, was evaluated using Receiver Operating Characteristics, Area Under the Curve (AUC), Kaplan-Meier curves, and Cox proportional Hazard ratios. The FI-Lab showed an AUC of 0.7177 for 6-month and 0.7423 for 1-year survival. High FI-Lab values correlated with higher preoperative ASA scores, longer time-to-surgery times, more perioperative transfusions, and higher postoperative complication rates. The Cox hazard ratio revealed a significant increase in the risk of death for 1 year and 6 months from a score of 0.4 and higher. These findings highlight the FI-Lab's clinical relevance and validity as a predictive tool, emphasizing the need for differentiated perioperative risk stratification.
No takes yet. Share an insight, caveat, or question.
Liodakis et al. (2025) conducted a cohort in Hip fracture (n=235). Laboratory-based frailty index (FI-Lab21) vs. Lower FI-Lab21 scores (0-0.1) was evaluated on 1-year all-cause mortality (HR 6.507, 95% CI 2.751-17.89, p=<0.0001). A laboratory-based frailty index (FI-Lab21) score greater than 0.5 was associated with a significantly increased risk of 1-year mortality (HR 6.507) compared to a score of 0-0.1 in elderly patients with hip fractures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: